FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Boehringer Ingelheim Pharmaceuticals Persantine Recall

Persantine (dipyridamole USP) tablets, 75 mg, 100-count bottles, Rx only, Dist

Boehringer Ingelheim Pharmaceuticals, Inc. · Ridgefield, CT

Risk level
Class II
Reported by FDA
Nov 2, 2016
Recall ID
D-0113-2017
Check your lot numberHow we source this data

Summary

Boehringer Ingelheim Pharmaceuticals recalled Persantine starting Oct 6, 2016. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0113-2017 on Nov 2, 2016. Reason: Presence of foreign tablets/capsules: 50 mg Persantine tablets were found in a 75 mg Persantine 100-count bottle and 50 mg Persantine tablet was found in a 100 count bottle of 75 mg Dipyridamole. Status: Terminated.

Why it was recalled

Presence of foreign tablets/capsules: 50 mg Persantine tablets were found in a 75 mg Persantine 100-count bottle and 50 mg Persantine tablet was found in a 100 count bottle of 75 mg Dipyridamole.

Product description

Persantine (dipyridamole USP) tablets, 75 mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877, NDC 0597-0019-01

Lot numbers, UPCs & expiration codes

Lot #:456520, Exp. 5/17

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0113-2017
Classification
Class II
Status
Terminated
Recall initiated
Oct 6, 2016
FDA report date
Nov 2, 2016
Quantity
2562 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Boehringer Ingelheim Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0113-2017, exactly as published.

Show all FDA fields
City
Ridgefield
State
CT
Status
Terminated
Country
United States
Event ID
75374
Address
900 Ridgebury Rd
Code information
Lot #:456520, Exp. 5/17
Postal code
06877-1058
Report date
Nov 2, 2016
Product type
Drugs
Recall number
D-0113-2017
Classification
Class II
Recalling firm
Boehringer Ingelheim Pharmaceuticals, Inc.
Product quantity
2562 bottles
Termination date
Nov 29, 2017
Reason for recall
Presence of foreign tablets/capsules: 50 mg Persantine tablets were found in a 75 mg Persantine 100-count bottle and 50 mg Persantine tablet was found in a 100 count bottle of 75 mg Dipyridamole.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Persantine (dipyridamole USP) tablets, 75 mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim (BI) Pharmaceuticals, Inc., Ridgefield, CT 06877, NDC 0597-0019-01
Distribution pattern
Nationwide
Recall initiation date
Oct 6, 2016
Initial firm notification
Letter
Center classification date
Oct 24, 2016

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0113-2017, published Nov 2, 2016. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls